Association analysis of the tumor necrosis factor gene polymorphisms (TNFA 238 and 302) in the development of schizophrenia: Impact on the antipsychotic treatment response

Gene Therapy and Molecular Biology

Volumn 13, Issue 1, 2009, Pages 152-157

  Pae, Chi Un ^a,b   Drago, Antonio ^c   Chiesa, Alberto ^c   Mandelli, Laura ^c   Serretti, Alessandro ^c   Jun, Tae Youn ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Clinical variables; Schizophrenia; Tumor necrosis factor gene

Indexed keywords

EID: 77649317332     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. American PA (1994). "Diagnostic and Statistical Manual of Mental Disorder, fourth ed., ." American Psychiatric Press, Washington DC.
2. Boin F, Zanardini R, Pioli R, Altamura CA, Maes M, and Gennarelli M (2001) Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry 6, 79-82.
3. Czerski PM, Rybakowski F, Kapelski P, Rybakowski JK, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Slopien A, Skibinska M, Kaczmarkiewicz-Fass M, and Hauser J (2008) Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population. Neuropsychobiology 57, 88-94.
4. Duan S, Xu Y, Chen W, Liu Z, Guo T, Gao J, Bian L, Zhen Y, Li X, Zhang X, Pan Y, Gu N, Feng G, and He L (2004) No association between the promoter variants of tumor necrosis factor alpha (TNF-alpha) and schizophrenia in Chinese Han population. Neurosci Lett 366, 139-43.
5. Erbagci AB, Herken H, Koyluoglu O, Yilmaz N, and Tarakcioglu M (2001) Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Mediators Inflamm 10, 109-15.
6. First MB, Spitzer RL, Gibbon M, and Williams JBW (1997). "Structured Clinical Interview for DSM-IV-Clinician Version (SCID-CV)." American Psychiatric Press, Washington DC.
7. Handoko HY, Nancarrow DJ, Hayward NK, Ohaeri JU, Aghanwa H, McGrath JJ, Levinson DF, Johns C, Walters MK, Nertney DA, Srinivasan TN, Thara R, and Mowry BJ (2003) Tumor necrosis factor haplotype analysis amongst schizophrenia probands from four distinct populations in the Asia-Pacific region. Am J Med Genet B Neuropsychiatr Genet 121B, 1-6.
8. Hanninen K, Katila H, Rontu R, Mattila KM, Hurme M, and Lehtimaki T (2005) Tumor necrosis factor-alpha -G308A polymorphism in schizophrenia in a Finnish population. Neurosci Lett 385, 76-81.
9. Hashimoto R, Yoshida M, Ozaki N, Yamanouchi Y, Iwata N, Suzuki T, Kitajima T, Tatsumi M, Kamijima K, and Kunugi H (2004) Association analysis of the -308G>A promoter polymorphism of the tumor necrosis factor alpha (TNF-alpha) gene in Japanese patients with schizophrenia. J Neural Transm 111, 217-21.
10. Holden RJ, and Pakula IS (1999) Tumor necrosis factor-alpha: is there a continuum of liability between stress, anxiety states and anorexia nervosa? Med Hypotheses 52, 155-62.
11. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, and Hoehler T (2000) Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 114, 1180-3.
12. Kampman O, Anttila S, Illi A, Mattila KM, Rontu R, Leinonen E, and Lehtimaki T (2005) Interaction of tumor necrosis alpha -G308A and epidermal growth factor gene polymorphisms in early-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 255, 279-83.
13. Kay SR, Opler LA, and Lindenmayer JP (1988) Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 23, 99-110.
14. Kubota T, Fang J, Guan Z, Brown RA, and Krueger JM (2001) Vagotomy attenuates tumor necrosis factor-alpha-induced sleep and EEG delta-activity in rats. Am J Physiol Regul Integr Comp Physiol 280, R1213-20.
15. Meira-Lima IV, Pereira AC, Mota GF, Floriano M, Araujo F, Mansur AJ, Krieger JE, and Vallada H (2003) Analysis of a polymorphism in the promoter region of the tumor necrosis factor alpha gene in schizophrenia and bipolar disorder: further support for an association with schizophrenia. Mol Psychiatry 8, 718-20.
16. Monteleone P, Fabrazzo M, Tortorella A, and Maj M (1997) Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment. Psychiatry Res 71, 11-7.
17. Morar B, Schwab SG, Albus M, Maier W, Lerer B, and Wildenauer DB (2007) Evaluation of association of SNPs in the TNF alpha gene region with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 144B, 318-24.
18. Muller N, and Ackenheil M (1998) Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 22, 1-33.
19. Naudin J, Capo C, Giusano B, Mege JL, and Azorin JM (1997) A differential role for interleukin-6 and tumor necrosis factoralpha in schizophrenia? Schizophr Res 26, 227-33.
20. Pae CU, Chae JH, Bahk WM, Han H, Jun TY, Kim KS, Kwon YS, and Serretti A (2003) Tumor necrosis factor-alpha gene polymorphism at position -308 and schizophrenia in the Korean population. Psychiatry Clin Neurosci 57, 399-403.
21. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, and Pollmacher T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58, 445-52.
22. Riedel M, Kronig H, Schwarz MJ, Engel RR, Kuhn KU, Sikorski C, Sokullu S, Ackenheil M, Moller HJ, and Muller N (2002) No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia. Eur Arch Psychiatry Clin Neurosci 252, 232-4.
23. Sacchetti E, Bocchio-Chiavetto L, Valsecchi P, Scassellati C, Pasqualetti P, Bonvicini C, Corsini P, Rossi G, Cesana BM, Barlati S, and Gennarelli M (2007) -G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: meta-analysis plus association study. Brain Behav Immun 21, 450-7.
24. Saviouk V, Chow EW, Bassett AS, and Brzustowicz LM (2005) Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44. Mol Psychiatry 10, 375-83.
25. Schwab SG, Hallmayer J, Albus M, Lerer B, Eckstein GN, Borrmann M, Segman RH, Hanses C, Freymann J, Yakir A, Trixler M, Falkai P, Rietschel M, Maier W, and Wildenauer DB (2000) A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry 5, 638-49.
26. Schwab SG, Mondabon S, Knapp M, Albus M, Hallmayer J, Borrmann-Hassenbach M, Trixler M, Gross M, Schulze TG, Rietschel M, Lerer B, Maier W, and Wildenauer DB (2003) Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophrenia. Schizophr Res 65, 19-25.
27. Serretti A, Macciardi F, Cusin C, Lattuada E, Lilli R, Di Bella D, Catalano M, and Smeraldi E (1999) No interaction of GABA(A) alpha-1 subunit and dopamine receptor D4 exon 3 genes in symptomatology of major psychoses. Am J Med Genet 88, 44-9.
28. Sham PC, and Curtis D (1995) Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59, 97-105.
29. Shirts BH, Bamne M, Kim JJ, Talkowski M, Wood J, Yolken R, and Nimgaonkar VL (2006) A comprehensive genetic association and functional study of TNF in schizophrenia risk. Schizophr Res 83, 7-13.
30. Strieter RM, Kunkel SL, and Bone RC (1993) Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med 21, S447-63.
31. Tan EC, Chong SA, Tan CH, Teo YY, Peng K, and Mahendran R (2003) Tumor necrosis factor-alpha gene promoter polymorphisms in chronic schizophrenia. Biol Psychiatry 54, 1205-11.
32. Tsai SJ, Hong CJ, Yu YW, Lin CH, and Liu LL (2003) No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine. Schizophr Res 65, 27-32.
33. Watanabe Y, Muratake T, Kaneko N, Fukui N, Nara Y, and Someya T (2007) No association between the tumor necrosis factor-alpha gene promoter polymorphisms and schizophrenia in a Japanese population. Psychiatry Res 153, 1-6.
34. Wilson AG, Gordon C, di Giovine FS, de Vries N, van de Putte LB, Emery P, and Duff GW (1994) A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 24, 191-5.
35. Xie X, and Ott J (1993) Testing linkage disequilibrium between a disease gene and marker loci. Am. J. Hum. Genet. 53, (Suppl) 1107.
36. Zai G, Muller DJ, Volavka J, Czobor P, Lieberman JA, Meltzer HY, and Kennedy JL (2006) Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication. Psychopharmacology (Berl) 188, 171-82.
37. Zhao JH (2004) 2LD, GENECOUNTING and HAP: Computer programs for linkage disequilibrium analysis. Bioinformatics 20, 1325-6.